Prevention Strategies for Antimicrobial Resistance: a Systematic Review of the Literature

Overview

Journal Infect Drug Resist

Publisher Dove Medical Press

Date 2011 Jun 23

PMID 21694891

Citations 15

Authors

Whitney P Caron

Shaker A Mousa

Affiliations

Soon will be listed here.

Abstract

Antibiotics offer great benefits by reducing the duration and severity of illnesses and aiding in infection transmission control. With this being said, the inexorable process of antimicrobial drug resistance is to some degree unavoidable. Although drug resistance will likely persist and is to be expected, the overall level can be dramatically decreased with increased attention to antibiotic overuse and the pharmacokinetic and pharmacodynamic properties of different drug formulations, and the use of proper hygiene and protective barriers. Implementation of such practices as microbial surveillance and prophylaxis has been shown to result in decreased hospital length of stay, health care costs and mortality due to drug-resistant infections. This review will summarize current progress in preventative techniques aimed at reducing the incidence of infection by antimicrobial-resistant bacteria and the emergence and spread of antimicrobial-resistant strains. By employing a variety of prevention strategies, including proper personal hygiene, prescreening for carrier status before hospital admission, disinfection of hospital rooms, and careful monitoring of antimicrobial prescribing, marked progress can be achieved in the control of drug-resistant pathogens, which can translate into more effective antimicrobial therapy.

Citing Articles

Detection, characterization, and antibiotic resistance profiling of multidrug-resistant bacteria isolated from circulating currency in the Northeastern region of Bangladesh.

Mishu M, Imran A, Saha A, Ferdousee S, Islam M, Abdullah-Al-Shoeb M IJID Reg. 2025; 14():100519.

PMID: 39835186 PMC: 11743309. DOI: 10.1016/j.ijregi.2024.100519.

Navigating antibiotic therapy in acute cholangitis: Best practices and new insights.

Masuda S, Imamura Y, Jinushi R, Kimura K, Ryozawa S, Koizumi K J Hepatobiliary Pancreat Sci. 2024; 32(1):44-57.

PMID: 39537571 PMC: 11780307. DOI: 10.1002/jhbp.12087.

New Agents Are Coming, and So Is the Resistance.

Keck J, Viteri A, Schultz J, Fong R, Whitman C, Poush M Antibiotics (Basel). 2024; 13(7).

PMID: 39061330 PMC: 11273847. DOI: 10.3390/antibiotics13070648.

Efficacy of Short-Course Antibiotic Therapy for Acute Cholangitis With Positive Blood Cultures: A Retrospective Study.

Masuda S, Imamura Y, Ichita C, Jinushi R, Kubota J, Kimura K Cureus. 2024; 16(4):e58883.

PMID: 38800172 PMC: 11117024. DOI: 10.7759/cureus.58883.

Association of short-course antimicrobial therapy and bacterial resistance in acute cholangitis: Retrospective cohort study.

Masuda S, Jinushi R, Imamura Y, Kubota J, Kimura K, Shionoya K Endosc Int Open. 2024; 12(2):E307-E316.

PMID: 38420157 PMC: 10901644. DOI: 10.1055/a-2230-8229.

References

Bennett K, Scarborough J, Sharpe M, Dodds-Ashley E, Kaye K, Hayward 3rd T . Implementation of antibiotic rotation protocol improves antibiotic susceptibility profile in a surgical intensive care unit. J Trauma. 2007; 63(2):307-11. DOI: 10.1097/TA.0b013e318120595e. View

Noskin G, Rubin R, Schentag J, Kluytmans J, Hedblom E, Smulders M . The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med. 2005; 165(15):1756-61. DOI: 10.1001/archinte.165.15.1756. View

Dong Y, Zhao X, Domagala J, Drlica K . Effect of fluoroquinolone concentration on selection of resistant mutants of Mycobacterium bovis BCG and Staphylococcus aureus. Antimicrob Agents Chemother. 1999; 43(7):1756-8. PMC: 89357. DOI: 10.1128/AAC.43.7.1756. View

Shiomori T, Miyamoto H, Makishima K, Yoshida M, Fujiyoshi T, Udaka T . Evaluation of bedmaking-related airborne and surface methicillin-resistant Staphylococcus aureus contamination. J Hosp Infect. 2002; 50(1):30-5. DOI: 10.1053/jhin.2001.1136. View

McBryde E, Bradley L, Whitby M, McElwain D . An investigation of contact transmission of methicillin-resistant Staphylococcus aureus. J Hosp Infect. 2004; 58(2):104-8. DOI: 10.1016/j.jhin.2004.06.010. View

Zell B, Goldmann D . Healthcare-associated infection and antimicrobial resistance: moving beyond description to prevention. Infect Control Hosp Epidemiol. 2007; 28(3):261-4. DOI: 10.1086/513722. View

Muto C, Jernigan J, Ostrowsky B, Richet H, Jarvis W, Boyce J . SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol. 2003; 24(5):362-86. DOI: 10.1086/502213. View

Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher H, Scheld W . The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(2):155-64. DOI: 10.1086/524891. View

Klevens R, Edwards J, Tenover F, McDonald L, Horan T, Gaynes R . Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis. 2006; 42(3):389-91. DOI: 10.1086/499367. View

10.

Hoffman . Pharmacodynamic aspects of sustained release preparations. Adv Drug Deliv Rev. 2000; 33(3):185-199. DOI: 10.1016/s0169-409x(98)00027-1. View

11.

Cosgrove S . The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin Infect Dis. 2005; 42 Suppl 2:S82-9. DOI: 10.1086/499406. View

12.

Zhao X, Drlica K . Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies. Clin Infect Dis. 2001; 33 Suppl 3:S147-56. DOI: 10.1086/321841. View

13.

Jurkovich P . Home- versus hospital-laundered scrubs: a pilot study. MCN Am J Matern Child Nurs. 2004; 29(2):106-10. DOI: 10.1097/00005721-200403000-00009. View

14.

. Antibiotic overuse: the influence of social norms. J Am Coll Surg. 2008; 207(2):265-75. DOI: 10.1016/j.jamcollsurg.2008.02.035. View

15.

Gross P, Patel B . Reducing antibiotic overuse: a call for a national performance measure for not treating asymptomatic bacteriuria. Clin Infect Dis. 2007; 45(10):1335-7. DOI: 10.1086/522183. View

16.

Altermann W, Kazmierczak J . Archean microfossils: a reappraisal of early life on Earth. Res Microbiol. 2003; 154(9):611-7. DOI: 10.1016/j.resmic.2003.08.006. View

17.

Nicolle L, Bradley S, Colgan R, Rice J, Schaeffer A, Hooton T . Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis. 2005; 40(5):643-54. DOI: 10.1086/427507. View

18.

Madaras-Kelly K, Remington R, Lewis P, Stevens D . Evaluation of an intervention designed to decrease the rate of nosocomial methicillin-resistant Staphylococcus aureus infection by encouraging decreased fluoroquinolone use. Infect Control Hosp Epidemiol. 2006; 27(2):155-69. DOI: 10.1086/500060. View

19.

Mody L, Kauffman C, McNeil S, Galecki A, Bradley S . Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003; 37(11):1467-74. PMC: 3319403. DOI: 10.1086/379325. View

20.

Siegel J, Rhinehart E, Jackson M, Chiarello L . Management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control. 2007; 35(10 Suppl 2):S165-93. DOI: 10.1016/j.ajic.2007.10.006. View